Alamar Biosciences IPO

alamarbio.com

Alamar biosciences developing medical platforms in the field of proteomics to enable the early detection of cancer and other diseases.

Founded2018
Total Funding to Date$120.9MM
Register for Details

For more details on financing and valuation for Alamar Biosciences, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Alamar Biosciences Ticker Symbol

Alamar Biosciences does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

Alamar Biosciences Stock Price

The stock price for Alamar Biosciences will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Alamar Biosciences Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
10/15/2021 Series B-Plus $390.1MM $XXX.XX $XXX.XX
9/8/2021 Series B $312.15MM $XXX.XX $XXX.XX
5/26/2020 Series A-1, A-2, A-3, and A-4 $72.79MM $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Other companies like Alamar Biosciences in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$317.32MM
Sector
 
 
Sector
Last Round Est. Valuation
$1.59B
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$334.19MM